50 research outputs found
Efficient Battery Usage in Wireless-Powered Cell-Free Systems with Self-Energy Recycling
This paper investigates wireless-powered cell-free systems, in which the
users send their uplink data signal while simultaneously harvesting energy from
network nodes and user terminals - including the transmitting user terminal
itself - by performing self-energy recycling. In this rather general setting, a
closed-form lower bound of the amount of harvested energy and the achieved
signal-to-interference-plus-noise ratio expressions are derived. Then, to
improve the energy efficiency, we formulate the problem of minimizing the
users' battery energy usage while satisfying minimum data rate requirements.
Due to the non-convexity of the problem, a novel alternating optimization
algorithm is proposed, and its proof of convergence is provided. Finally,
numerical results show that the proposed method is more efficient than a
state-of-art algorithm in terms of battery energy usage and outage rate.Comment: Accepted as a correspondance at IEEE TV
Mixed Coherent and Non-Coherent Transmission for Multi-CPU Cell-Free Systems
Existing works on cell-free systems consider either coherent or non-coherent
downlink data transmission and a network deployment with a single central
processing unit (CPU). While it is known that coherent transmission outperforms
noncoherent transmission when assuming unlimited fronthaul links, the former
requires a perfect timing synchronization, which is practically not viable over
a large network. Furthermore, relying on a single CPU for geographically large
cell-free networks is not scalable. Thus, to realize the expected gains of
cellfree systems in practice, alternative transmission strategies for realistic
multi-CPU cell-free systems are required. Therefore, this paper proposes a
novel downlink data transmission scheme that combines and generalizes the
existing coherent and non-coherent transmissions. The proposed transmission
scheme, named mixed transmission, works based on the realistic assumption that
only the access points (APs) controlled by a same CPU are synchronized, and
thus transmit in a coherent fashion, while APs from different CPUs require no
synchronism and transmit in a non-coherent manner. We also propose extensions
of existing clustering algorithms for multi-CPU cell-free systems with mixed
transmission. Simulation results show that the combination of the proposed
clustering algorithms with mixed transmission have the potential to perform
close to the ideal coherent transmission.Comment: Submitted for possible publication in IEEE conferenc
A Distributed Game-Theoretic Solution for Power Management in the Uplink of Cell-Free Systems
This paper investigates cell-free massive multiple input multiple output
systems with a particular focus on uplink power allocation. In these systems,
uplink power control is highly non-trivial, since a single user terminal is
associated with multiple intended receiving base stations. In addition, in
cell-free systems, distributed power control schemes that address the inherent
spectral and energy efficiency targets are desirable. By utilizing tools from
game theory, we formulate our proposal as a noncooperative game, and using the
best-response dynamics, we obtain a distributed power control mechanism. To
ensure that this power control game converges to a Nash equilibrium, we apply
the theory of potential games. Differently from existing gamebased schemes,
interestingly, our proposed potential function has a scalar parameter that
controls the power usage of the users. Numerical results confirm that the
proposed approach improves the use of the energy stored in the battery of user
terminals and balances between spectral and energy efficiency.Comment: Accepted at IEEE Globecom 202
Guarana (Paullinia cupana var. sorbilis), an anciently consumed stimulant from the Amazon rain forest: the seeded-fruit transcriptome.
Guarana (Paullinia cupana var. sorbilis) is a plant native to the central Amazon basin. Roasted seed extracts have been used as medicinal beverages since pre-Colombian times, due to their reputation as stimulants, aphrodisiacs, tonics, as well as protectors of the gastrointestinal tract. Guarana plants are commercially cultivated exclusively in Brazil to supply the national carbonated soft-drink industry and natural product stores around the world. In this report, we describe and discuss the annotation of 15,387 ESTs from guarana seeded-fruits, highlighting sequences from the flavonoid and purine alkaloid pathways, and those related to biotic stress avoidance. This is the largest set of sequences registered for the Sapindaceae family
Beaked whales respond to simulated and actual navy sonar
This article is distributed under the terms of the Creative Commons Public Domain declaration. The definitive version was published in PLoS One 6 (2011): e17009, doi:10.1371/journal.pone.0017009.Beaked whales have mass stranded during some naval sonar exercises, but the cause is unknown. They are difficult to sight but can reliably be detected by listening for echolocation clicks produced during deep foraging dives. Listening for these clicks, we documented Blainville's beaked whales, Mesoplodon densirostris, in a naval underwater range where sonars are in regular use near Andros Island, Bahamas. An array of bottom-mounted hydrophones can detect beaked whales when they click anywhere within the range. We used two complementary methods to investigate behavioral responses of beaked whales to sonar: an opportunistic approach that monitored whale responses to multi-day naval exercises involving tactical mid-frequency sonars, and an experimental approach using playbacks of simulated sonar and control sounds to whales tagged with a device that records sound, movement, and orientation. Here we show that in both exposure conditions beaked whales stopped echolocating during deep foraging dives and moved away. During actual sonar exercises, beaked whales were primarily detected near the periphery of the range, on average 16 km away from the sonar transmissions. Once the exercise stopped, beaked whales gradually filled in the center of the range over 2–3 days. A satellite tagged whale moved outside the range during an exercise, returning over 2–3 days post-exercise. The experimental approach used tags to measure acoustic exposure and behavioral reactions of beaked whales to one controlled exposure each of simulated military sonar, killer whale calls, and band-limited noise. The beaked whales reacted to these three sound playbacks at sound pressure levels below 142 dB re 1 µPa by stopping echolocation followed by unusually long and slow ascents from their foraging dives. The combined results indicate similar disruption of foraging behavior and avoidance by beaked whales in the two different contexts, at exposures well below those used by regulators to define disturbance.The research reported here was financially supported by the United States (U.S.) Office of Naval Research (www.onr.navy.mil) Grants N00014-07-10988,
N00014-07-11023, N00014-08-10990; the U.S. Strategic Environmental Research and Development Program (www.serdp.org) Grant SI-1539, the Environmental
Readiness Division of the U.S. Navy (http://www.navy.mil/local/n45/), the U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance), the
U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology) (http://www.st.nmfs.noaa.gov/), U.S.
National Oceanic and Atmospheric Administration Ocean Acoustics Program (http://www.nmfs.noaa.gov/pr/acoustics/), and the Joint Industry Program on Sound
and Marine Life of the International Association of Oil and Gas Producers (www.soundandmarinelife.org)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.
Iron Behaving Badly: Inappropriate Iron Chelation as a Major Contributor to the Aetiology of Vascular and Other Progressive Inflammatory and Degenerative Diseases
The production of peroxide and superoxide is an inevitable consequence of
aerobic metabolism, and while these particular "reactive oxygen species" (ROSs)
can exhibit a number of biological effects, they are not of themselves
excessively reactive and thus they are not especially damaging at physiological
concentrations. However, their reactions with poorly liganded iron species can
lead to the catalytic production of the very reactive and dangerous hydroxyl
radical, which is exceptionally damaging, and a major cause of chronic
inflammation. We review the considerable and wide-ranging evidence for the
involvement of this combination of (su)peroxide and poorly liganded iron in a
large number of physiological and indeed pathological processes and
inflammatory disorders, especially those involving the progressive degradation
of cellular and organismal performance. These diseases share a great many
similarities and thus might be considered to have a common cause (i.e.
iron-catalysed free radical and especially hydroxyl radical generation). The
studies reviewed include those focused on a series of cardiovascular, metabolic
and neurological diseases, where iron can be found at the sites of plaques and
lesions, as well as studies showing the significance of iron to aging and
longevity. The effective chelation of iron by natural or synthetic ligands is
thus of major physiological (and potentially therapeutic) importance. As
systems properties, we need to recognise that physiological observables have
multiple molecular causes, and studying them in isolation leads to inconsistent
patterns of apparent causality when it is the simultaneous combination of
multiple factors that is responsible. This explains, for instance, the
decidedly mixed effects of antioxidants that have been observed, etc...Comment: 159 pages, including 9 Figs and 2184 reference